Those immunosuppressive IL17+ Foxp3+ T cells were described for instance in human colorectal and esophageal cancers, but not in ovarian cancer, melanoma, or renal cell carcinoma [87–91]. This evidence concerns the gene IL17A and ovarian carcinoma.